Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Research Center of Rational Drug Use is a prominent research and consulting organization specializing in health technology assessment (HTA) and pharmacoeconomics. The center plays a critical role in the development of clinical guidelines and the evaluation of drug efficacy and cost-effectiveness to support healthcare decision-making. It primarily serves regulatory bodies and pharmaceutical companies, providing expert analysis for drug reimbursement and inclusion in essential medicines lists. Based in Moscow, the organization is a key influencer in the Russian healthcare landscape, promoting evidence-based medicine and the rational allocation of medical resources. Its services include market access strategy, clinical trial design consulting, and educational programs for healthcare professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Center of Rational Drug Use.